Cytokinetics crunchbase
WebApr 7, 2024 · Annual Report to Security Holders (ars) April 07 2024 - 04:08PM. Edgar (US Regulatory) This regulatory filing also includes additional resources: edge20006209x502_ars.pdf. Cytokinetics (NASDAQ:CYTK) Historical Stock Chart. From Mar 2024 to Apr 2024. WebCytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators as potential treatments …
Cytokinetics crunchbase
Did you know?
WebNov 18, 2024 · Based in South San Francisco, CA, Cytokinetics is a small health care company with only 130 employees and an annual revenue of $55.8M. The Organization’s Mission To improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function. Industry Biotechnology Revenue … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle … Cytokinetics has 6 current employee profiles, including Recruiter Daniel … Cytokinetics has raised a total of $1.1B in funding over 8 rounds. Their latest … The intellectual property of Cytokinetics includes 192 registered patents primarily … Edit Recent News & Activity Section. Number of Articles 67. News • Apr 3, … Cytokinetics is a biopharmaceutical company developing therapies for …
WebCytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets +0.85 Home CYTK • NASDAQ Cytokinetics, Inc. Follow Share $35.84 Apr 3, 9:39:48 AM GMT-4 · … WebMar 4, 2024 · SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that positive results from Cohort 4 of REDWOOD-HCM ( R andomized E...
WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential … WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled...
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential...
WebGet Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. ottawa lrt alstomWebJan 17, 2024 · Currently, the analyst consensus on Cytokinetics is a Strong Buy with an average price target of $64.00, implying a 49.2% upside from current levels. In a report issued on January 6, Mizuho... rock topographyWebFeb 24, 2024 · cytokine, any of a group of small, short-lived proteins that are released by one cell to regulate the function of another cell, thereby serving as intercellular chemical … rocktops granite and stone plainview txWebPeople Detect online and real-world risks to leadership, personnel, and partners. Places Mitigate physical and digital threats against facilities, infrastructure, and assets. Position Defend your global standing and reputation in the … rocktops granite plainviewWebMar 31, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … rock tops granite plainview texasWebcytokine: [noun] any of a class of immunoregulatory proteins (such as interleukin or interferon) that are secreted by cells especially of the immune system. rocktops granite and stone fabrication llcWebJan 7, 2024 · SOUTH SAN FRANCISCO, Calif. and NEW YORK, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Cytokinetics has... rocktop technologies careers